Literature DB >> 28414147

Public access to clinical trials: Lessons from an organizational implementation of policy.

Grant D Huang1, Jane K Altemose2, Timothy J O'Leary3.   

Abstract

Efforts to make clinical trials and their results more publicly available have been increasing in recent years. However, there is a need to better understand ways to achieve these goals aimed at benefiting a diverse set of stakeholders. Since 2005, the U.S. Department of Veterans Affairs Office of Research and Development (ORD), part of the nation's largest integrated health care system, has required the clinical trials its funds to be registered in ClinicalTrials.gov as a condition of the award. Furthermore, summary results of studies active since 2007 have been included in the registry. This paper highlights ORD activities, challenges and lessons at investigator, study, and organizational levels. Key factors in ORD's approach include: a mission-oriented approach; leadership support; a working group for organizational policies and practices; prioritizing communication; and recognizing the needs of investigators. Making clinical trials available to the public should represent a focal point for groups desiring to maximize the contributions from such research. The ability to do so must involve a commitment by sponsors and a critical evaluation of the reasons, requirements and resources at multiple levels. Published by Elsevier Inc.

Keywords:  Access; Clinical trials; ClinicalTrials.gov; Policy; Veterans

Mesh:

Year:  2017        PMID: 28414147     DOI: 10.1016/j.cct.2017.04.002

Source DB:  PubMed          Journal:  Contemp Clin Trials        ISSN: 1551-7144            Impact factor:   2.226


  5 in total

1.  Comparison of Data on Serious Adverse Events and Mortality in ClinicalTrials.gov, Corresponding Journal Articles, and FDA Medical Reviews: Cross-Sectional Analysis.

Authors:  Richeek Pradhan; Sonal Singh
Journal:  Drug Saf       Date:  2018-09       Impact factor: 5.606

2.  Evidence Map: Reporting of Results by Sex or Gender in Randomized, Controlled Trials with Women Veteran Participants (2008 to 2018).

Authors:  Elisheva R Danan; Kristen Ullman; Ruth S Klap; Elizabeth M Yano; Erin E Krebs
Journal:  Womens Health Issues       Date:  2019-06-25

3.  Marketing training strategies that pharmaceutical sales managers use to reduce unethical behavior.

Authors:  Aseel Bin Sawad; Kate Andrews
Journal:  J Educ Health Promot       Date:  2022-06-30

4.  Clinical trial registration and reporting: a survey of academic organizations in the United States.

Authors:  Evan Mayo-Wilson; James Heyward; Anthony Keyes; Jesse Reynolds; Sarah White; Nidhi Atri; G Caleb Alexander; Audrey Omar; Daniel E Ford
Journal:  BMC Med       Date:  2018-05-02       Impact factor: 8.775

5.  An initiative using informatics to facilitate clinical research planning and recruitment in the VA health care system.

Authors:  Kandi E Velarde; Jennifer M Romesser; Marcus R Johnson; Daniel O Clegg; Olga Efimova; Steven J Oostema; Jeffrey S Scehnet; Scott L DuVall; Grant D Huang
Journal:  Contemp Clin Trials Commun       Date:  2018-07-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.